tiprankstipranks
Arcus Biosciences Inc (RCUS)
NYSE:RCUS
US Market

Arcus Biosciences (RCUS) Income Statement

Compare
476 Followers

Arcus Biosciences Income Statement

Last quarter (Q4 2024), Arcus Biosciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Arcus Biosciences's net income was $-94.00M. See Arcus Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 258.00M$ 117.00M$ 112.00M$ 383.00M$ 77.52M
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―$ ―$ ―
EBITDA
$ -263.00M$ -285.00M$ -258.00M$ 59.00M$ -120.00M
Operating Income
$ -330.00M$ -340.00M$ -280.00M$ 54.00M$ -124.23M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -283.00M$ -307.00M$ -267.00M$ 53.00M$ -123.00M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Arcus Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis